Ayurvedic nutrition startup Kapiva has raised $60 million (around Rs 500 crore) in a Series D funding round, led by 360 ONE Asset and Vertex Growth. Existing backers, including Vertex Ventures SEA & India and 3one4 Capital, also participated in the round. Early investor Fireside Ventures fully exited through this deal.
Funding Details and Investor Exit
-
Of the total $60 million, $28 million came as primary capital, while the rest was secondary, facilitating Fireside Ventures’ exit.
-
This round began in September 2024 with a $10 million investment from OrbiMed Asia, Vertex Ventures, and 3one4 Capital.
-
With the latest infusion, Kapiva’s total funding now stands close to $90 million.
How Kapiva Plans to Use the Funds
Kapiva said the fresh capital will be directed towards:
-
Research & Development (R&D) for new product innovation
-
Expanding manufacturing capacity
-
Brand building and marketing
-
Scaling its health tech platform for chronic condition management and personalised care
Company Performance and Growth
Founded in 2015 by Ameve Sharma and Shrey Badhani, Kapiva has positioned itself as a leading Ayurveda-based nutrition and wellness brand. Its product portfolio covers diabetes, hypertension, liver health, hormonal balance, immunity, energy, and sports nutrition.
-
Annual revenue run rate: Around Rs 550 crore, up from Rs 350 crore in FY25.
-
Growth rate: More than 80% CAGR over the last three years.
-
Profitability: Currently slightly EBITDA-negative, but expects to turn profitable in the upcoming quarter.
-
FY24 numbers: Revenue doubled to Rs 228 crore, while losses narrowed to Rs 56 crore.
Market Presence and Competition
Kapiva products are sold via its website, major ecommerce platforms, and offline retail stores, reaching nearly 40,000 outlets across India.
In the Ayurveda wellness segment, Kapiva competes with Innovacare, Gynoveda, and Wellbeing Nutrition, which are also scaling rapidly in the Indian and global markets.
Future Outlook
With fresh funding and strong revenue growth, Kapiva is aiming for profitability and deeper penetration in the Ayurveda-based wellness sector. The company’s investment in R&D and personalised healthcare solutions could give it an edge in the growing chronic care and preventive wellness market in India.
FAQs About Kapiva’s Funding and Business
1. How much did Kapiva raise in its latest funding round?
Kapiva raised $60 million in Series D funding, led by 360 ONE Asset and Vertex Growth.
2. Which investor exited during this round?
Early investor Fireside Ventures made a full exit through the secondary share sale.
3. What will Kapiva use the fresh funds for?
The funds will be used for R&D, manufacturing expansion, brand building, and scaling its health tech platform.
4. How is Kapiva performing financially?
Kapiva has an annual revenue run rate of Rs 550 crore, grew revenue twofold in FY24, and expects to achieve profitability soon.
5. Who are Kapiva’s competitors in the Ayurveda wellness market?
Its key competitors include Innovacare, Gynoveda, and Wellbeing Nutrition.